LTK CRYOSOLUTIONS, the new Basque spin-off set to revolutionise the handling of cell therapies, is launched
LTK Cryosolutions (www.ltkcryo.com) is launching CryoKeep, a technology-based project spearheaded by the Leartiker technology centre and the University of Navarra Clinic (CUN) for the development, manufacture and commercialisation of a pioneering medical device designed for cell therapies.
The device — a patent-protected cryo-syringe — combines, in a single step, the cryogenic storage of the cell sample and its subsequent administration to the patient. This solution simplifies operations for both the laboratory and the clinical team, increases treatment safety and improves the culture yield, meeting the needs of a fast-growing industry with over 1,000 clinical trials currently underway internationally.
Born out of the combined knowledge and experience of Leartiker and the CUN, the new company is backed by Basque Tek Ventures (BTV) and its roadmap envisages, together with other financial partners, an industrial facility in the Lea Artibai area (Bizkaia), with an estimated creation of highly skilled jobs.
In this new phase, LTK CRYOSOLUTIONS is commencing the clinical validation and certification phase for its first commercial product, a prerequisite for initial sales and the roll-out of a complete range of solutions for the processing, handling and cryopreservation of cell therapies.

About LTK Cryosolutions
A technology company based in Markina-Xemein (Bizkaia), in which Leartiker S. Coop. and the University of Navarra Clinic hold stakes, dedicated to optimising operations in cell therapies and personalised medicine.
About Leartiker
Leartiker is a specialised centre for the generation and transfer of scientific and technological knowledge to drive innovation and business competitiveness in the fields of: polymeric materials and advanced manufacturing processes; biomaterials, biomanufacturing and biomedical engineering; and healthy and sustainable food. Through applied research and technological development, it offers solutions designed to address the challenges faced by businesses, combining scientific and technological capabilities with close collaboration with the industrial sector. Based in Markina-Xemein, it has a multidisciplinary team committed to creating economic and social value. As a cooperative within the MONDRAGON Corporation, LEARTIKER operates under a sustainable and collaborative business model, maintaining its commitment to knowledge transfer, regional development and improving the competitiveness of organisations.
About the University of Navarra Clinic (Clínica Universidad de Navarra - CUN)
The University of Navarra Clinic (CUN) is a leading academic hospital, committed to excellence in patient care, biomedical research and the training of healthcare professionals. Through a patient-centred model based on personalised medicine, it integrates clinical practice, translational research and teaching to offer innovative solutions in the prevention, diagnosis and treatment of diseases. With sites in Pamplona and Madrid, it boasts a highly qualified multidisciplinary team and state-of-the-art technology, all dedicated to delivering the highest quality healthcare. Affiliated with the University of Navarra, the CUN operates with a firm commitment to innovation, the generation of knowledge and the continuous improvement of people’s health and wellbeing, establishing itself as a leading institution in the national and international healthcare sector.
